First Trust NYSE Arca Biotechnology Index Fund
250 hedge funds and large institutions have $510M invested in First Trust NYSE Arca Biotechnology Index Fund in 2025 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 62 increasing their positions, 101 reducing their positions, and 30 closing their positions.
1.7% less ownership
Funds ownership: 52.29% → 50.59% (-1.7%)
7% less funds holding
Funds holding: 269 → 250 (-19)
12% less capital invested
Capital invested by funds: $578M → $510M (-$67.7M)
39% less repeat investments, than reductions
Existing positions increased: 62 | Existing positions reduced: 101
53% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 30
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$7.28M |
| 2 |
AFA
Arlington Financial Advisors
Santa Barbara,
California
|
+$4.25M |
| 3 |
Goldman Sachs
New York
|
+$2.37M |
| 4 |
HFP
Holistic Financial Partners
Indianapolis,
Indiana
|
+$1.93M |
| 5 |
MWM
Modern Wealth Management
Lenexa,
Kansas
|
+$1.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SFGP
Stonebridge Financial Group (Pennsylvania)
Wormleysburg,
Pennsylvania
|
-$13.1M |
| 2 |
CAG
Csenge Advisory Group
Clearwater,
Florida
|
-$8.23M |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$6.51M |
| 4 |
Two Sigma Investments
New York
|
-$5.75M |
| 5 |
MIG
McGuire Investment Group
Wakefield,
Rhode Island
|
-$5.18M |
FBT Hedge Fund Activity: Q2 2025 in Review
250 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in First Trust NYSE Arca Biotechnology Index Fund (FBT) for Q2 2025, worth a combined $510M — down 12% from $578M a quarter earlier.
Sellers outnumbered buyers: 30 funds closed out of FBT and 14 opened new positions — a net loss of 16 holders — while 101 trimmed existing stakes and 62 added.
The largest buyer was Susquehanna International Group, adding an estimated $7.28M. The largest seller was Stonebridge Financial Group (Pennsylvania), exiting entirely with an estimated $13.1M sold.
- 250 institutional investors held First Trust NYSE Arca Biotechnology Index Fund (FBT) as of Q2 2025, down from 269 in Q1 2025.
- Funds reported $510M of First Trust NYSE Arca Biotechnology Index Fund stock for Q2 2025, down 12% quarter-over-quarter.
- 14 funds opened new First Trust NYSE Arca Biotechnology Index Fund positions in Q2 2025 and 30 closed out, a net change of -16 holders.
- The largest First Trust NYSE Arca Biotechnology Index Fund buyer in Q2 2025 was Susquehanna International Group, an estimated $7.28M added.
- The largest First Trust NYSE Arca Biotechnology Index Fund seller in Q2 2025 was Stonebridge Financial Group (Pennsylvania), an estimated $13.1M sold.
Based on aggregated 13F filings for Q2 2025.